Former UAB president, Vestavia Hills Mayor Charles ‘Scotty’ McCallum dies
Updated Jan 16, 2021;
Posted Jan 16, 2021
Former UAB President and two-term Vestavia Hills Mayor Charles Scotty McCallum died early Saturday. McCallum attended a groundbreaking ceremony for the UAB Football Operations Center and Legacy Pavilion in August 2016. (Joe Songer/jsonger@al.com). al.comal.com
Facebook Share
McCallum’s son, Chris, posted on Facebook that his father died early today.
“Dad made it to heaven at 205 this am,” Chris McCallum wrote. “If you knew him he made you part of his family!”
McCallum became the third president of UAB in 1987 and served until 1993. McCallum also served the university as vice president for Health Affairs, dean of the School of Dentistry and chair of the Department of Oral Surgery. He later served two terms as mayor of Vestavia Hills.
iStock; Everyday Health
Fatalities tied to synthetic opioids and illegal fentanyl climbed 38.4 percent in the 12 months ending in May 2020, compared with the same period ending in May 2019, according to the CDC. The spike in overdose deaths tied to these substances was even steeper in several parts of the country, almost doubling in 10 Western states.
In addition, overdose deaths involving psychostimulants such as methamphetamine increased by 34.8 percent, exceeding the total number of fatalities involving cocaine. Overdose deaths from cocaine climbed 26.5 percent, likely due to combined use with illegally manufactured fentanyl or heroin, the CDC reports.
There are likely several reasons why drug overdose deaths have surged since the onset of the COVID-19 pandemic, says Alana Vivolo-Kantor, PhD, lead health scientist at the division of overdose prevention at the CDC in Atlanta. These include a larger supply of illegal drugs, reduced access to addiction and overdose treatment, and
According to a study carried out by the researchers at the University of Alabama at Birmingham, use of the diabetes drug metformin before a diagnosis of Covid-19 is associated with a threefold d
Metformin drug decreases mortality rate in COVID-19 patients with type 2 diabetes
Use of the diabetes drug metformin before a diagnosis of COVID-19 is associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes, according to a racially diverse study at the University of Alabama at Birmingham. Diabetes is a significant comorbidity for COVID-19.
This beneficial effect remained, even after correcting for age, sex, race, obesity, and hypertension or chronic kidney disease and heart failure.
Anath Shalev, M.D, Study Lead Author and Director of Comprehensive Diabetes Center, University of Alabama at Birmingham Since similar results have now been obtained in different populations from around the world including China, France and a UnitedHealthcare analysis this suggests that the observed reduction in mortality risk associated with metformin use in subjects with Type 2 diabetes and COVID-19 might be generalizable, Shalev said.